echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Nature back-to-back multiomics maps molecular subtypes of human fetal cerebellar developing medulloblastoma

    Nature back-to-back multiomics maps molecular subtypes of human fetal cerebellar developing medulloblastoma

    • Last Update: 2022-10-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Written by | Medulloblastoma

    (MB), usually caused by cerebellar dysplasia, is a typical childhood malignancy
    .
    The cerebellum originates from
    the rhombic lip (RL) in the dorsal part of the posterior wing plate, an area responsible for generating all excitatory neurons that are then internalized into nodules
    .
    Anatomically, RL is separated by the vascular bed and divided into
    two parts: the ventricular zone (RL VZ) and the subventricular zone (RLSVZ).


    There are four molecular subsets involved in MB, namely WNT, SHH, group 3 and group 4 [1].

    。 Among them, WNT MBs originate from bryophytic fibrous neurons in the dorsal brainstem during the embryonic stage, while SHH and type 3/4 MB are thought to originate in the cerebellum
    .
    Type 3/4 MB accounts for 65% of clinical diagnoses, and MRI shows that it occupies most or all of the fourth ventricle, making it difficult for neuroscientists to track its origin
    anatomically.
    At the molecular level, the characteristics of type 3/4 MB are also unclear
    .
    Although the single-cell map of the developing mouse cerebellum has been depicted
    [2,3], it provides some opportunity
    to infer the origin of different MB subtypes.
    However, due to species differences, it
    is urgent to analyze the relationship between human cerebellar development and MB (especially 3/4 type MB) for the construction of accurate disease models and the formulation of clinical treatment plans.


    Recently, Paul A.
    Northcott's group from St.
    Jude Children's Research Hospital and Kathleen J.
    Millen's group from Seattle Children's Research Institute published a report in Nature titled
    Unified rhombic lip origins of group 3 and group 4 Medulloblastoma's article uses multiomics techniques to reveal the origin of the subpopulation of medulloblastoma during human cerebellar development and describe its molecular and phenotypic characteristics
    .


    The authors first used transcriptome data from 52,419 single cells and nuclei in the cerebellum of the human fetus (9-21 weeks after pregnancy) to map different molecular subsets of MB back to specific cell types
    in cerebellar development at the bulk level.
    SHH MB was found
    to be closer to the transcriptome of granule neuron progenitors (GNPs), type 3 MB corresponding to human embryonic RL, type 4 MB corresponding to RL, glutamatergic cerebellar nuclear neurons (glutamatergic).
    cerebellar nuclear neuron)
    or unipolar brush cell (commonly referred to as GlutaCN/UBC because the two are difficult to distinguish
    ).
    Subsequently, through quasi-temporal analysis, the authors found that type 3/4 MB cells fit well with early progenitor cells of the GlutaCN/UBC lineage, and type 4 MB cells have a higher
    degree of differentiation.
    Correspondingly, the results obtained by fitting MB subsets with cerebellar single-cell data were also consistent
    .

    To further confirm the relationship between type 3/4 MB and human RL–GlutaCN/UBC lineages, the authors microdissected RL samples and 7 external granule layer (EGL) samples from 7 human embryos (14-21 weeks' gestation) methylation was
    mapped.
    EGL acts as a transient
    germinal zone during cerebellar development, enriching a large number of proliferating GNPs
    .
    Methylation-based classification showed that all EGL samples were classified as SHH-MB, while RL pointed to type 3 MB, but the score of type 4 MB was low
    .
    The above conclusions comprehensively show that type 3/4 MB corresponds to GlutaCN/UBC lineage progenitor cells located in RL and differentiates
    along this trajectory.

    Subsequently, the authors introduced bulk RNA-seq datasets of human embryonic cerebellar subregions (subcompartments) to further refine the transcriptome atlas
    .
    The study found that RLVZ signaling was enriched in primitive RL cells in stem cell state, while RLSVZ signaling was more enriched in
    progenitor cells with RL–GlutaCN/UBC development trajectories.
    Subregion-specific gene set analysis of bulk MB expression profile also confirmed that SHH MB significantly enriched EGL expression characteristics, while type 3/4 MB significantly enriched RLSVZ characteristics
    .
    As expected, another gene set also showed significant enrichment of
    UBC in the RLSVZ region.

    Notably, the RLSVZ region identified photoreceptor signals
    associated with the retina.
    3.
    Type 4 MB has different high-expression RLSVZ genes, type 3 MB expresses a large number of classical photoreceptor
    markers (such as EYS, GNB3, CRX, RPGRIP1), and type 4 MB highly expresses different UBC markers (such as EOMES, BARHL1, DDX31, LMX1A).

    。 The immunostaining results of 43 patients' tumors were consistent with gene expression, with type 3 MB tumors expressing CRX and type 4 MB tumors expressing EOMES, and intermediate tumors expressing both, but the levels were relatively reduced
    .
    For decades, the origin of the photoreceptor expression characteristics of type 3 MB has been unclear
    [4-6].

    In both the human embryonic cerebellum and MB, the authors observed a strong correlation
    between the transcription factor OTX2 and the expression of RLSVZ photoreceptor signaling.
    CRISPR–Cas9 gene editing experiments demonstrated that OTX2 is necessary for maintaining photoreceptor expression in type 3 MB and can inhibit glutamatergic neuron differentiation in MB
    .

    Next, in order to explore the genetic pathology of type 3/4 MB, the authors integrated the somatic mutation annotations of 324 cases of type 3/4 MB and found that GFI1B enhancer hijacking was significant in both subsets, which directly led to the BARHL1–DDX31 site Structural variation
    (locus).
    The hijacking frequency of BARHL1–DDX31 sites in type 3/4 MB is the same, and combined with the similarity of gene expression patterns in RLSVZ above, the authors believe that the use of multi-omics evaluation can better illustrate the origin
    of RL in type 3/4 MB.
    Combined with the evaluation of CHIP-seq, ATAC-seq, RNA-seq and methylation levels, the study found 3DDX31 transcription is active and chromatin is open in /4 MB, and DDX31 is mostly inactivated
    in SHH MB.
    In the GFI1B-activated 3/4 MB, the authors detected structural variation in the window of 4.
    6 kb of the last intron of DDX31, and further found that the different methylation states of RL and EGL were relatively high methylation in SHH MB and human embryonic EGL samples, while both type 3/4 MB and human embryonic RL samples showed demethylation characteristics
    .

    Finally, the authors analyzed the atlases of 235,331 single cells in the mouse cerebellum and found that there was no enrichment of photoreceptor signaling from RLSVZ- in any cell type
    .
    Transcriptome analysis showed that Eomes in mice was mainly expressed in late-mitotic, metastatic and mature UBCs born in RL, while in the human brain, it was abundantly expressed in RLSVZ progenitor cells rather than more differentiated UBCs
    .
    All of the above shows that the cerebellar development of mice and humans varies greatly at the molecular level, and this study identified some human-specific characteristics
    .
    In addition, MRI of 'small MBs' showed different tumor localization for different
    MB subtypes.


    In general, this paper reveals the unknown lineage origin of type 3/4 MB, changes the previous perception that type 3 and 4 MB are completely independent entities, and describes its corresponding molecular signals, cell states, biological pathways and clinical phenotypes, and anatomical diagnostic sites, which are clinical MB Risk assessment and diagnosis (especially non-WNT/non-SHH MBs) provide guidance
    .

    During the same period, Michael D.
    Taylor's team at The Hospital for Sick Children in Canada published back-to-back articles in Nature
    Failure of human rhombic lip differentiation underlies The medulloblastoma formation also reveals the important role
    of labial differentiation in MB.


    Original link:

    https://doi.
    org/10.
    1038/s41586-022-05208-9

    https://doi.
    org/10.
    1038/s41586-022-05215-w


    Pattern maker: Eleven

    References


    1.
    Northcott, P.
    A.
    et al.
    Medulloblastoma.
    Nat.
    Rev.
    Dis.
    Primers 5, 11 (2019).
    2.
    Hovestadt, V.
    et al.
    Resolving medulloblastoma cellular architecture by single-cellgenomics.
    Nature 572, 74–79 (2019).
    3.
    Vladoiu, M.
    C.
    et al.
    Childhood cerebellar tumours mirror conserved fetal transcriptionalprograms.
    Nature 572, 67–73 (2019).
    4.
    Cho, Y.
    J.
    et al.
    Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.
    J.
    Clin.
    Oncol.
    29, 1424–1430 (2011).
    5.
    Kool, M.
    et al.
    Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.
    PLoS One 3,e3088 (2008).
    6.
    Northcott, P.
    A.
    et al.
    Medulloblastoma comprises four distinct molecular variants.
    J.
    Clin.
    Oncol.
    29, 1408–1414 (2011).

    Reprint instructions

    【Original Article】BioArt original article, individuals are welcome to forward and share, reprinting is prohibited without permission, and the copyright of all works published is owned
    by BioArt.
    BioArt reserves all statutory rights and will be prosecuted
    for non-compliance.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.